Skip to main content

Table 2 Prior medications used for existing hypertension and proteinuria

From: Adherence to long-term use of renin-angiotensin II-aldosterone system inhibitors in children with chronic kidney disease

Concomitant medications

Overall (n = 1271)

PDC < 80 (n = 1056)

PDC ≥ 80 (n = 215)

Hypertension, n, %

1114

87.65

912

86.36

202

93.95

 C02 (antihypertensive)

24

1.89

12

1.14

12

5.58

 C03 (diuretics)

193

15.18

153

14.49

40

18.60

 C04 (vasodilators)

94

7.40

78

7.39

16

7.44

 C07 (beta-blockers)

61

4.80

40

3.79

21

9.77

 C08C (dihydropyridines)

130

10.23

90

8.52

40

18.60

 C08D (non-dihydropyridines)

10

0.79

6

0.57

4

1.86

 C09 (RASI)

1078

84.82

882

83.52

196

91.16

Proteinuria, n, %

679

53.42

525

49.72

154

71.63

 Corticosteroids

660

51.93

510

48.30

150

69.77

 L04 (immunosuppressants)

247

19.43

170

16.10

77

35.81

 L01 (anti-neoplastic agents)

131

10.31

97

9.19

34

15.81

 P02 (mycophenolate)

40

3.15

34

3.22

6

2.79

  1. PDC proportion of days covered during study follow-up. Concomitant medication use was categorized using ATC codes for the sum of 90 days of supply within one year prior to the RASI index date
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us